TL - Honey - I hope the info gives you hope - I found this on Pub Med:
Safety considerations favour recombinant products, while overall outcome and cost considerations favour urinary gonadotrophins. Outcome, however, appears to differ, based on age and ovarian function, with younger patients benefiting from the FSH/LH combination offered by urinary products, while older women and young women with ovarian resistance, apparently benefiting from pure FSH stimulation. Young women with poor ovarian reserve may be best stimulated with a pure FSH/antagonist protocol.

I think it speaks of the benefit of straight FSH without combining other drups for people with ovarian resistance - I think!

Melsta - It is a consequence of having an overactive imagination and a determination to do nothing that even closely resembles work!